Apoptosis Assays Market Projected to Expand at a CAGR of 8.5%, Elevating to a Valuation of USD 11.3 billion by 2034 | Analysis by Transparency Market Research Inc.
August 13, 2024 03:47 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Aug. 13, 2024 (GLOBE NEWSWIRE) -- The global apoptosis assay market (세포사멸 분석 시장) was projected to attain US$ 4.6 billion in...
BioStem Technologies Reports Record Second Quarter 2024 Revenue of $74.5 Million
August 12, 2024 16:14 ET
|
Biostem Technologies
BioStem Technologies Reports Record Second Quarter 2024 Revenue of $74.5 Million
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study
August 12, 2024 16:10 ET
|
OncoCyte Corporation
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study
Priority OnDemand Rebrands Digital Patient Logistics Division to OnDemand Connect
August 12, 2024 10:06 ET
|
Priority OnDemand
Knoxville, TN, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Priority OnDemand, a leading provider of healthcare solutions, announced today the rebranding of its digital patient logistics division, formerly...
NEXGEL to Report Second Quarter 2024 Financial Results on August 14th
August 12, 2024 09:15 ET
|
NEXGEL, INC.
Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., Aug. 12, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading...
Dr. Charlie Fox Joins Utah Gastroenterology in Salt Lake City
August 12, 2024 08:15 ET
|
GI Alliance
Salt Lake City, UT, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Utah Gastroenterology is proud to welcome Dr. Charlie Fox, a board-certified gastroenterologist who treats all GI issues while specializing in...
Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial
August 12, 2024 05:00 ET
|
Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Juillet 2024
August 09, 2024 15:11 ET
|
Sanofi - Aventis Groupe
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés...
Sanofi: Information concerning the total number of voting rights and shares - July 2024
August 09, 2024 15:11 ET
|
Sanofi - Aventis Groupe
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement...
Metabolomics Market Surges to USD 7.22 Billion by 2031, Propelled by 13.13% CAGR - Verified Market Research®
August 09, 2024 10:15 ET
|
Verified Market Research
Lewes, Delaware, Aug. 09, 2024 (GLOBE NEWSWIRE) -- The Global Metabolomics Market Size is projected to grow at a CAGR of 13.13% from 2024 to 2031, according to a new report published by Verified...